It was reported that FTO, a key m6A demethylase, was up-regulated and significantly associated with poor prognosis in breast cancer (8); FTO-reduced m6A modification could promote breast cancer cell proliferation and metastasis by inhibiting BNIP3 expression (11). This evidence concerns the gene FTO and breast cancer.